Hypertrophic Cardiomyopathy Center, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.
Hypertrophic Cardiomyopathy Center, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.
J Thorac Cardiovasc Surg. 2015 Oct;150(4):928-35.e1. doi: 10.1016/j.jtcvs.2015.07.063. Epub 2015 Jul 26.
We sought to assess the long-term outcomes in patients with hypertrophic cardiomyopathy and severe left ventricular outflow tract obstruction, in whom the decision regarding surgery (vs conservative management) was based on assessment of symptoms or exercise capacity.
This was an observational study of 1530 patients with hypertrophic cardiomyopathy (aged 50 ± 13 years, 63% were men) with severe left ventricular outflow tract obstruction (excluding those aged <18 years, with left ventricular ejection fraction <50%, and with left ventricular outflow tract gradient <30 mm Hg). A composite end point of death (excluding noncardiac causes) and/or implantable defibrillator discharge was assessed.
Coronary artery disease, family history of hypertrophic cardiomyopathy, and syncope were present in 15%, 17%, and 18% of patients, respectively, whereas 73% patients were in New York Heart Association class II or greater. Mean left ventricular ejection fraction, basal septal thickness, and left ventricular outflow tract gradient (resting or provocable) were 62% ± 5%, 2.2 ± 1 cm, and 101 ± 39 mm Hg, respectively. A total of 858 patients (56%) underwent exercise echocardiography, of whom 503 (59%) had exercise capacity impairment. At 8.1 ± 6 years, 990 patients (65%) underwent surgical relief of left ventricular outflow tract obstruction, and 540 patients (35%) did not. There were 156 events (10%) (134 deaths), with 0% 30-day mortality in the surgical group. On multivariable Cox proportional hazard analysis, increasing age (hazard ratio [HR], 1.20), coronary artery disease (HR, 1.68), worse New York Heart Association class (HR, 1.46), and atrial fibrillation (HR, 1.90) predicted higher events, whereas surgery (time-dependent covariate HR, 0.57) was associated with improved event-free survival (all P < .01).
In patients with hypertrophic cardiomyopathy and severe left ventricular outflow tract obstruction, in whom the decision regarding surgery was based on the presence of intractable symptoms and impaired exercise capacity, surgery was associated with significant improvement in long-term composite outcomes.
我们旨在评估肥厚型心肌病伴严重左心室流出道梗阻患者的长期预后,这些患者的手术(vs 保守治疗)决策基于症状或运动能力评估。
这是一项针对 1530 名肥厚型心肌病患者(年龄 50±13 岁,63%为男性)的观察性研究,这些患者伴严重左心室流出道梗阻(不包括年龄<18 岁、左心室射血分数<50%以及左心室流出道梯度<30mmHg 的患者)。评估了复合终点事件(排除非心脏原因导致的死亡和/或植入式除颤器放电)。
分别有 15%、17%和 18%的患者存在冠状动脉疾病、肥厚型心肌病家族史和晕厥,而 73%的患者处于纽约心脏协会(NYHA)心功能分级 II 级或更高级别。平均左心室射血分数、基底室间隔厚度和左心室流出道梯度(静息或激发时)分别为 62%±5%、2.2±1cm 和 101±39mmHg。共有 858 名(56%)患者接受了运动超声心动图检查,其中 503 名(59%)存在运动能力受损。在 8.1±6 年时,990 名(65%)患者接受了左心室流出道梗阻的手术缓解治疗,而 540 名(35%)患者未接受手术。共有 156 例(10%)事件(134 例死亡),手术组无 30 天死亡率(0%)。多变量 Cox 比例风险分析显示,年龄增长(风险比[HR],1.20)、冠状动脉疾病(HR,1.68)、NYHA 心功能分级恶化(HR,1.46)和心房颤动(HR,1.90)与更高的事件风险相关,而手术(时变协变量 HR,0.57)与改善的无事件生存相关(均 P<.01)。
在肥厚型心肌病伴严重左心室流出道梗阻且手术决策基于难治性症状和运动能力受损的患者中,手术与长期复合结局的显著改善相关。